Professor | Hao Jiang | Asia Growth Partners

Upload Avatar (500 x 500)

Name

Hao Jiang

Contact Information

jianghao1209@csu.edu.cn

Language ability

Chinese, English

Province

Hunan

University/Lab Affiliation and Title	Central South University
Faculty	Life Sciences
Academic Background & Achievements	2013-2017 Doctor of Science: University of Chinese Academy of Sciences / East China University of Science and Technology 2010-2013 Master of Science: Northeast Normal University 2006-2010 Bachelor of Science: Northeast Normal University Hosted 1 national project and 2 provincial projects, received the 'Lotus Tip' talent title in Hunan
Work Experience	2017.7-2019.12 South China University of Technology - Postdoctoral Researcher 2020.6-2023.9 Central South University - Lecturer 2023.9-present Central South University - Associate Professor

University/Lab Affiliation and Title

Central South University

Faculty

Life Sciences

Academic Background & Achievements

2013-2017 Doctor of Science: University of Chinese Academy of Sciences / East China University of Science and Technology
2010-2013 Master of Science: Northeast Normal University
2006-2010 Bachelor of Science: Northeast Normal University
Hosted 1 national project and 2 provincial projects, received the 'Lotus Tip' talent title in Hunan

Work Experience

Areas of Focus	Exploration of epigenetic modifiers in cancer development and progression, discovery of precision treatment drugs
Publications	Targeting C21orf58 is a Novel Treatment Strategy of Hepatocellular Carcinoma by Disrupting the Formation of JAK2/C21orf58/STAT3 Complex, Hao Jiang et al., 2024 COX6C expression driven by copy amplification of 8q22.2 regulates cell proliferation via mediation of mitosis by ROS-AMPK signaling in lung adenocarcinoma, Hao Jiang et al., 2024 STAT5a and SH2B3 novel mutations display malignancy roles in a triple-negative primary myelofibrosis patient, Hao Jiang et al., 2023 Deubiquitinase OTUD3: a double-edged sword in immunity and disease, Hao Jiang et al., 2023 Immunostimulant nanomodulator boosts antitumor immune response in triple negative breast cancer by synergism of vessel normalization and photothermal therapy, Hao Jiang et al., 2023 Identification of a CircRNA-miRNA-mRNA Network and Integrated Analysis of Immune Infiltration in Oral Squamous Cell Carcinoma, Hao Jiang et al., 2023 Fringe family genes and their modulation of Notch signaling in cancer, Hao Jiang et al., 2022 Upregulated GATA3/miR205-5p Axis Inhibits MFNG Transcription and Reduces the Malignancy of Triple-Negative Breast Cancer, Hao Jiang et al., 2022 Chromatin remodeling factor ARID2 suppresses hepatocellular carcinoma metastasis via DNMT1-Snail axis, Hao Jiang et al., 2020

Areas of Focus

Exploration of epigenetic modifiers in cancer development and progression, discovery of precision treatment drugs

Publications

Targeting C21orf58 is a Novel Treatment Strategy of Hepatocellular Carcinoma by Disrupting the Formation of JAK2/C21orf58/STAT3 Complex, Hao Jiang et al., 2024
COX6C expression driven by copy amplification of 8q22.2 regulates cell proliferation via mediation of mitosis by ROS-AMPK signaling in lung adenocarcinoma, Hao Jiang et al., 2024
STAT5a and SH2B3 novel mutations display malignancy roles in a triple-negative primary myelofibrosis patient, Hao Jiang et al., 2023
Deubiquitinase OTUD3: a double-edged sword in immunity and disease, Hao Jiang et al., 2023
Immunostimulant nanomodulator boosts antitumor immune response in triple negative breast cancer by synergism of vessel normalization and photothermal therapy, Hao Jiang et al., 2023
Identification of a CircRNA-miRNA-mRNA Network and Integrated Analysis of Immune Infiltration in Oral Squamous Cell Carcinoma, Hao Jiang et al., 2023
Fringe family genes and their modulation of Notch signaling in cancer, Hao Jiang et al., 2022
Upregulated GATA3/miR205-5p Axis Inhibits MFNG Transcription and Reduces the Malignancy of Triple-Negative Breast Cancer, Hao Jiang et al., 2022
Chromatin remodeling factor ARID2 suppresses hepatocellular carcinoma metastasis via DNMT1-Snail axis, Hao Jiang et al., 2020

Epigenetics Cancer Tumor Precision Medicine Drug Discovery Mechanism Therapy Clinical Treatment Malignant Progression Treatment Strategies

Jiang Cizhong - Tongji University

Jiuhong Kang - Tongji University

Zhiwei Cao - Tongji University

View All

Personal Information